Tue, 5/10 4:51PM • 1:41:35
SUMMARY KEYWORDS
vaccine, virus, vaccines, methylene blue, polarization, polarize, protein, problem, interleukin, patient, immune system, macrophages, spike, receptor, pneumonia, block, leads, call, peptides, inflammation
SPEAKERS
Bill Clearfield
00:49
Hey, how are you?
Bill Clearfield 00:51
Oh, you know me I’m having a time in my life and
00:53
you. Great, great, great, great, right.
Bill Clearfield 00:56
Did you end up going to a forum last week?
00:59
Yeah, of course. I did. I did go today for him. And it was it was cool. Maybe it’s gonna join you today. Who’s that? Clouds. Join you joining us. He’s gonna join you now.
Bill Clearfield 01:21
Look at these fancy slides you got. Yeah, yeah, better. You’re getting better at it.
01:27
Dr. Mike beamer catch.
Bill Clearfield 01:29
Yeah, okay, well
01:33
you know, it helps attracting all those colors you know, it’s part of marketing. Part of the deal like your hours life, how is your business going? Your patients?
Bill Clearfield 01:48
The patients are okay. My Businesses. Yeah, you know, you know how life is he says.
01:56
Dr. Joseph James in pathology reporting a lot of success. Especially better with cancer. Use of James with others complicated autoimmune fatigue and chronic diseases. They’re doing a good job. They’re trying to open up a center in Texas. With Dr. John Ronald and Dr. Youssef. Awesome be my car life he’s going to join us. If we can get this excellency clinic going, then it’s working. Then Hey, we can have a clinic in its state. Yeah, like the class is joining me as well and putting the clinics together so that’s the beauty of it.
02:51
Yeah,
02:53
so you’re doing good. Ah, yes, yes, I’m trying my best. Kind of binding them up and you know, share the knowledge and learning from them. I learned a lot from them as well and earning into the protocol. So I learned a lot from you as well, you know, yeah. A lot of good insight. And restoring hormonal balance. Yeah, that’s,
Bill Clearfield 03:30
that’s, that’s our thing. So right.
03:33
I see. You’re very passionate in that. Especially with naltrexone and peptides.
Bill Clearfield 03:40
Yeah, we like we like all that stuff.
03:44
Right. Right. Although peptides I don’t know how that’s well, you. It’s been hammered by by the Big Pharma and by by the government for no reason. Just because it’s working.
Bill Clearfield 04:00
Because it works. You know? What do you mean no reason. There’s always a reason.
04:06
Yeah. And it’s not well, that’s like typical reason. It’s money driven reason. Yes, but scientific reason. I don’t see it. So what about money, man? Well, that’s it. Right. So you know about that guy. The guy who came to your room is trying to push giving you credit for your innovations. So what he does is that he gives it goes through your tax and taxes and he can give you up to 40% of your tax money from the payroll based on just little evidence that you have. You have an innovative protocols, which you do, and your patients are doing great with your treatments, and you have something special and that’s it. And they can prove it very easily because they’re lawyers and they get you up to 40% from your payrolls, yourself or your staff for three years. So that was the that was that’s what they’re doing. Right?
05:18
Well, no,
Bill Clearfield 05:19
it sounds like a bunch of who
05:22
voted me.
05:24
Why not if they have some codes and their lawyers and they can go back and you know, and give you some tax return. Dr. Glads is moving forward with it. He just asked me for their phone number. I don’t know if he said he’s here he did you join them. You’re gonna watch these
05:46
smaller nations just flare off
05:47
and that is an indication of what will happen here
05:51
in the US, when we get into the season.
Bill Clearfield 06:19
All right, Dr. Loss I unmuted you by accident.
06:23
So unmute yourself
06:50
okay, so I’m admitting the people who see Yeah, I can see them. Right. Okay. Okay, so we got here, adding people here. We’re gonna have a good crowd tonight. Okay,
Bill Clearfield 07:03
well we always like a good crowd,
07:05
right.
Bill Clearfield 07:15
names here I don’t recognize Are they from your side?
07:20
Yeah, some of them maybe. I’m just sending a couple of texts there. Yeah, I have some fans too. I know
07:36
that much, but but, but they’re okay. Thank you, Bill. Do you know what Andy’s gonna be on today?
Bill Clearfield 07:50
Um, I haven’t yet here. He is. He’s he’s on now.
07:59
So okay,
08:10
yeah, I think you’re gonna get 30 people tonight. Okay, yes. Take me Don’t take my word. But
Bill Clearfield 08:18
we we’ve been getting between 25 and 30 just about every
08:23
Oh really? And I need to borrow some from you can borrow them all because there’s some trays there.
Bill Clearfield 08:30
Just give them back. Yeah, I need I need some more speakers though. You know, I got endless Tuesday’s to fill up here.
08:38
Oh, you have Dr. Bet out she has I know
Bill Clearfield 08:41
we got dogs. I know.
08:43
She’s here. I mean, she she came up to me and said Dr. Elissa, what’s up? Well, I have a case. It’s a pediatric case from India, one years old. And she had and he or she he I think he’s a boy. Neutral philia. No. Isn’t Ophelia lymphocytosis neutropenia della Samia and growth retardation and the WBC is 18,000. Wow. 15,000. So, she’s now joining Dr. Patella. You see it. So anyway, so Dr. Patel told me this patient this is one year old and when she told me 18,000 Web, see I was kind of cough. Okay, this is going to be leukemia. So I was little bit alarmed about the 18,000 and then lymphocytosis that goes with castor viral infection. But then isn’t Ophelia does not go with what you’re doing. There not much to cancer, although some cancer you may get some others be there. Maybe. I thought it’s leukemia lymphoblastic leukemia, but then, you know, we see 18,000 An adult it’s big but for pediatric it’s not. It’s only normal wage is from 6000 to 17,000. So for them, it’s okay for you less than two years. So it’s not that much. Hi. One of the beginning as you are treating adult patients and you got this number of course, you’re going to add lymphocytosis then we thinking about lymphoblastic leukemia, but then she told me could be silly at least D So, then I started looking and yes, in celiac disease, they will have is in a failure and therefore cytosis is not due to cytotoxic T cells. It is due to the CD forced T cells which is T helper. th two so she has extreme polarization to th two and seems like too much of the h2 and it’s the lymphocytosis but th two eventually leads to interleukin four interleukin four leads to is in Ophelia. So that’s one of the explanation and but that case was very interesting. Hopefully she will put together a good case for that and presented because we still need to investigate and look for stool analysis and because it could be celiac disease and some blood tests but but that case is very interesting because when we go into present today, and we’re gonna go back again to the Holy Grail, which is the immune polarization, we’re gonna see that there is exceptions so it does not apply for every case, you really need to analyze the results and getting all the cytokines profiled and possibly lymphocyte mapping in order to know exactly where the polarization is.
Bill Clearfield 12:01
Right. Okay, so it’s a little bit after five. We have a fair crowd. So we want to welcome everybody anybody who’s new. My name is Bill Clearfield. I’m the executive director of the American Osteopathic society rheumatic diseases. And also the Integrative Health Alliance. And the old timers know that we’ve been here for well over a year and a half. Every Tuesday night we have an integrative medicine webinar. We have some really terrific speakers. Dr. Hal Lhasa is our speaker tonight, and he’s kind of our patriarch here. He’s the one who actually got this ball going. He has his own group that he deals with on Monday nights. And we also we also are affiliated with Dr. Farr Sheehan and his his stem cell positions on Wednesday night. So Monday, Tuesday or Wednesday nights. You can always get one of us if you feel like you’re in need of some advanced education. Those of you who could just a couple of announcements those of you who I got word that we’re supposed to get the videos finally from the from the conference on by tomorrow. He told me by tomorrow we should have it now. We’ll get it up on our website by as soon as I as soon as I can. There then it’s going to be password protected. You know, because it was a paid. conference if anybody wants to, you know, join who was not there. Is accredited for 26 ama and 26 AOA category one CME credits and you’re more than welcome to you know, there’s a there’s a you know, there’s a fee for it, but you’re more than welcome to participate in that, especially if you need the credit. There’s also two pain management credits which you know, a lot of state licenses require and there’s also two hours of pain management two hours of ethics which you only need one or think you need to every four years and there was one hour of suicide prevention. So all of the state licenses at least on the West Coast, we cover those those those topics every year. We are I don’t know if can’t if you and John have anything to speak about for omad or you want to wait till till the end. So oh man is the AOA scientific convention. That’s our it’s an October in Boston. And we’re starting to gear up for that. That’s our second big you know in person and hopefully it’ll be in person this year. Finally. A big educational get together. We have these webinars.
15:05
I do have some fairly exciting news on that. One speakers for the on the cannabis side. Getting Jeff Chen Jordan Tischler, Jeff Chen is the founder of radical sciences doing real world, IRB, statistically sound. Large studies now using cannabis products that are currently in the marketplace. And one of the first studies the AC studies should be the manuscript should be accepted, hopefully by the end of next month. So there may be a couple published. Isa is a data that he’ll be able to share. Jordan Tischler, which is faculty at Harvard, founder of the Association of cannabinoid specialists is going to be a speaker and our are going to do Dustin Souillac will also be in attendance and and I’m attempting to get these three guys all with different skill sets in a panel, so that we can address some of the challenges in this space for clinicians, so it should be a really cool, four hours. Great.
16:46
For what it’s worth, I’ll go ahead and speak now because we’ve expanded the cannabis from four hours to eight hours, but we’re trying to deal with pleasantries and personalities. So we have the opportunity to do way more everything you’re talking about and more. But I just want this to be a very peaceful thing. So hey, Bill, Kant wants to talk to you and I after the doctor lost his talk. Okay,
Bill Clearfield 17:13
got it. Okay, so it’s a little bit after after five we have a pretty nice crowd so far. I’m gonna let Dr. Lawson he’s our speaker tonight. I’m gonna let him introduce himself. He’s been a leader, ever since the COVID. Business hit, he’s he’s been out in front with leading edge remedies, therapies and theories. And so I’m going to I’m going to turn it over to him so Dr. Philosophy take it away.
17:43
Sure, sure. So, yeah, we’re gonna talk tonight about plus COVID-19 syndrome and also about cause post COVID-19 vaccine injuries and both of them they share the common pathophysiology, which is the spike receptor. Are you recording now? Putting on the record. Okay, great. So yeah, we’re gonna talk about both COVID-19 syndrome and post COVID 19. Vaccine injuries are side effects. And we’re going to see how we can manage them. And we know that both have common methodology both of them they express the spike protein and the spike protein blocks the h2 receptor, which is very critical, because h2 enzyme is very important to convert angiotensin two to angiotensin one seven, which is the anti inflammatory arm of the angiotensin renin angiotensin system. And so we know for the fact those virus it gained the function or the gaining function research, which is those viruses are blocking critical enzyme on our body which is very critical because blocking angiotensin anti inflammatories, arm of angiotensin system can lead to cytokine storm and can lead to pro inflammatory cytokines that will lead to all this complications of COVID 19 infection and also because of all this cytokine storm leads to disturbance in the mitochondria function and the to function and autonomic nervous system and that’s why we have this post COVID-19 syndrome. Vaccine does the same thing because they express the spike protein the spike protein have days to so they have the anti inflammatory arm of the renin angiotensin system leading to overactive of the inflammatory arm which is mediated by angiotensin two type one receptor and that leads to an expression of interleukin six and polarization of the immune system into th 17. And then you would have what we call the neutrophilia and you will have neutrophilia pneumonia and it will feel like basketball lights all over the body and that leads to all this organ damage and failure and it goes to stimulate dose interleukin six can stimulate the platelets so it leads to an increase in the timer’s and clotting and we know that recently that FDA did restrict Johnson Johnson vaccines because they find out they express too much of Spike protein that leads to clotting and coagulation and stroke. And that’s why now it’s officially that FDA restrict the use to certain people but a nice state but they’re allowing it to be to be sold without any with no restrictions overseas. It seems like you know, other people have other people other words are from other countries. They’re not humans and it’s okay if we sell them Johnson Johnson vaccine for but they’re not just state this is being restricted. Are you adding because I see people alive and
Bill Clearfield 21:12
yeah,
21:14
I don’t have any 35 People now I told you is going to be more than 30 Right? Yeah, I don’t have any my crowds. That’s why right.
Bill Clearfield 21:23
I don’t have anybody in the waiting room that I just
21:25
add Dr. clout just now. All right. Okay, so let’s go ahead and let me see here. So this presentation aims to comprehensively describe the theology pathophysiology, clinical feature diagnostic methods, and the latest novel therapeutics in management of post COVID 19. infection and vaccination syndromes. A large proportion of patient discharged after being hospitalized for COVID infection after receiving the vaccine experience. We know it’s the same pathophysiology which is despite protein with resistance COVID-19 related symptoms or complication, post COVID-19 syndrome or post COVID 19 Vaccine Injury involve varieties of immune alterations include lymphopenia Why because you would have that th 17 hyperimmune response and polarization to nitro philia and that will deplete the whole immune system is in a state of producing lymphocyte they start producing neutrophils and neutrophils cannot kill those cells which be infected by the virus you really need to stop cytotoxic T cells. So you need to polarize the immune system to th one toxic T cells and one but it seems that the that when the macrophage eats those virus to COVID-19 because of the spike protein those macrophages, they get, they have receptors as well you know and they have ace two receptor and same thing like any other sales of macrophages can respond to the spike protein by blocking the anti inflammatory arm of the renin angiotensin system leading to over activation of angiotensin two type one signaling and that leads to the polarization of the macrophages into m 17. And then to p at 17 and nitro philia. And then it would have what we call the neutrophilic pneumonia. So, it is very important to understand the immune modulation and immune system and how we polarize the immune system. Why we have neutrophilia Why we have as you know, philia why we have basil philia and it’s an affiliate so we need to explain the whole polarization of the immune system including the adaptive immune system and
23:55
and that starts from the macrophages and the whole immune polarization and direction is based on what the macrophage eats. So if the macrophage eats bacteria, what will happen the macrophages breaks the bacteria proteins into peptides and protein fragments, and those fragments will react with the toll like receptors on the macrophages so the macrophages do have tongues taste they taste their bacteria proteins, and when they they taste it they sit the bacteria proteins after it’s been degraded into peptides throw toll like receptors on their surface so toll like receptors they are the tongues of the macrophages. That’s how they sense that this is bacteria. And what would happen when those peptides and those fragments of protein and bacteria react with talk right receptor on the macrophages. They polarize the macrophages into M seven and then M seven will start secreting interleukin six and then stimulate the polarization of the naive T cells into T at 17. And then t at 17 start secreting interleukin 17. And if you do constricts interleukin 17 will polarize the white blood cells and make them or move them into producing a general feeling base. Sorry neutrophils. So the M 17 leads to tf 17. And then all the cytokines that’s coming out from macrophages and th 17 leads to polarization of WBC into neutrophilia. So we have when we have neutrophilia When you do CVC differential and you see high neutrophils then you will think the polarization of the immune system is to T at 17 and 17. Okay, and that’s mean you may have bacterial infection or fungus infection. Okay, so when we when when the macrophages eats infected cells with viruses or cancer what would happen they break down the protein of viruses and cancers and those protein turns into peptides and protein fragments and then they react with toll receptors on the macrophages that signal the macrophages to polarize into m one and then m one starts secreting interleukin two and 12 and they polarize and 80 cells into th one and then the th one start stimulating the activation of cytotoxic T cells and cell cytotoxic T cells is responsible to destroy those infected cells with viruses and and those cancers by attacking them and releasing all those toxins and open up pores into their membranes called Porphyrins and blow them up. So in order to kill virus infected cells or infected with viruses or cancer, you need to have cytotoxic T cells and that’s why you will see lymphocytosis lymphocytosis is due to CDA cells right are increased and and they are battling and destroying either cancer cells or virus. So when you have lymphocytosis then you think oh this could be cancer or viral infection. This is general this is the holy grail of the immune immune mean polarization. Of course, there’s exceptions and we’re going to talk about those exceptions and in the coming slides and possibly win cases. Like Dr. Patel, she has a case that she told me that the case with lymphocytosis and basically or is an affiliate and we’re going to talk about it which it has to do with that they did lymphocytosis here it’s not the CDA, it’s the CD. He has to now what about if the macrophages eats you’re the self antigens, right? They eat self antigens, and they break them down into peptides and proteins and fragments. They will react with Toll like receptors on the macrophage and polarize the macrophage into N Rex and then eggs will secrete interleukin 10 and and what would happen they polarize the TN ag cells into T regs, and then into the content will suppress all those effector cells that th one th 217 But what would happen if the macrophage just eats the other genes or parasites proteins, those proteins will be broken down into peptides and fragments they react with receptors on the macrophage and polarize the macrophages into m two and then M to start secreting interleukin four and then that will lead to polarization of the naive T cells into th two and then th two will cause what differentiation b c into is you know, feel and basal field so this is the holy grail. This is the basic system anguish you need to learn in order to really understand what’s going on with COVID-19 because COVID-19 disease is to at 17 immune dominant disease. And normally, you know when the macrophage is infected cells with virus I’d like flu viruses. authorization is supposed to be lymphocytosis cytotoxic T cells, and then they will go on to kill those infected silver with virus. But what’s happened is this COVID-19 hijacked the renin angiotensin system and on those macrophages, you will see ace two receptor and they block them leading to angiotensin one digital and two types of angiotensin two type one receptor signaling to be overactive, which leads to expression of prejudice and sex and that leads to polarization of the immune system to th 17 and neutrophilia. And neutrophils cannot do much into destroying those infected cells with viruses. In fact, this over stimulation of neutrophils leads to neutrophilic pneumonia and destroy your own self. Blood vigils and lag and leads to all this pneumonia we call it neutrophilic pneumonia and also it leads to neutrophilic vasculitis and stimulates the calculations the platelets activation rates are mediated by interleukin six that’s been overproduced because of the bulk of the wrong or vulgarization of the immune system to wrong direction which is toward th 17 th 17 We use it for killing bacteria and fungus but not for the virus and this is how your immune system has been fooled by the virus and of course it’s this is engineered. They know this is going to happen. And it’s sort of immune suppression because you are pushing and polarizing immune system in the wrong direction by hijacking the redeem angiotensin system, which leads to polarization immune system T of 17 and eventually profili. So that’s that’s the COVID-19 so knowing that COVID-19 It’s th 17 dominant immune disease, then we can manage the COVID-19 based on that then we need to find the drugs that we have the th 17 and have them to do can six and have to do can 17 Whether it’s going to be FDA approved antibodies, we have many of them, they can have introduced in six receptors or interleukin 17 receptors, or we use repurposing drugs like ivermectin, hydroxychloroquine methylene, blue, serotonin reuptake inhibitors, all of this can help the expression of interleukin six so the mechanism of action of this drugs is inhabiting the interleukin six expression is inhibiting the polarization of immune system for th 17. So let’s go ahead and look at Dr. Peter C. Here, Dr. Peter Hotez is the
31:33
we also took on a decade ago, the interesting
31:37
weighing doctor, that Dr. fallacy and all other doctors they based their information on what Dr. Peter Hotez is saying, and I admire him in this presentation and the beginning of COVID-19. He was very honest, very sincere and everything he said. And we’re going to learn what you’re saying and I confirm everything what he’s saying. But then after he got the funds, and he started developing vaccines, there’s a lot of disinformation and he is calling us that we are doing to disinformation, but we’re going to go through his videos and find out who is doing the disinformation. So anyway, let’s start with Dr. Peter Hotez presentation here at time, the beginning of the COVID 19 pandemic, and how he is explaining to the audience here that there is difficulty in developing those vaccines because there’s a problem with safety. So that’s a good thing. And there’s many things that we’re going to learn from him. And I really admire everything
32:48
Coronavirus vaccines because we recognize these as enormous public health threats. And yet we’ve have not seen the big pharma guys and the biotechs rushing into this space. So we we partnered with a group at the New York Blood Center in the Galveston National Laboratory to take on the big scientific challenge of Coronavirus vaccines and I say a scientific challenge because one of the things that we’re not hearing a lot about is the unique potential safety problem of Coronavirus vaccines. This was first found in the early 1960s. We had the respiratory syncytial virus vaccines to children and it was done here in Washington with the NIH and Children’s National Medical Center that some of those kids who got the vaccine actually did worse. And I believe there were two deaths in the consequence of that study because what happens with certain types of respiratory virus vaccines, you get immunized and then when you get actually exposed to the virus, you get this kind of paradoxical immune enhancement phenomenon. And what how and we don’t entirely understand the basis.
33:57
So this is very important part of our past experience and developing vaccine again, this was biotrust unsecured virus, and it’s similar to COVID-19 that this vaccine, the proteins that they express, they polarize the immune system, into th seven team and into possibly th two. So away from cytotoxic T cells sustained by COVID-19. So it’s fooling the immune system. And what would happen when you have that then you would have this hyper immune response, which is to 17 Hyper immune response, and also because of polarization to do h2, you would have a lot of antibodies. But those antibodies can neutralize those three viruses, but they cannot do much in neutralizing and killing and destroying and clearing those cells infected with viruses, you need cytotoxic T cells. So because of this polarizations into either th two or th 17 which will lead either to is an affiliate pneumonia or neutrophilic pneumonia depending on which one is dominant. And that’s the problem with CTL virus vaccines. Of course he cannot explain it because I don’t think he has a clue about that. We have two kinds of inflammations, th one th two Ts 17 And I don’t think you understand that those sensitive virus proteins when the macrophage eats them, those fragments react with Toll like receptors on the macrophages and signaling depolarizations into TS 17 and th two, leading to Xena philic pneumonia or basophilic pneumonia. We’re gonna see that in the coming slides he has when he’s trying to perfect the COVID-19 he talked about is no philic pneumonia but we’re gonna talk about it in the coming slides. So that’s the problem. Okay, so that’s the problem of failing of this vaccine similar what’s going on with COVID-19 because the spike receptor, they do the same thing to polarization the immune system for kids 17 and needs to interfere with pneumonia. And it’s only to death and to death, not 14,000 deaths that’s happening with COVID-19 14,000 death, which is point 00 2% of people receive the COVID vaccine died from the vaccine and he denied that and when we go in the coming slides, he denied the death of any data from from the vaccine but it’s been reported in CDC. It’s point 002 of the debt from the vaccine now the deaths from from COVID virus itself is going to and he can argue yes the debt from covered virus is 100 times more than that from covered by vaccine and that’s true. But then and that’s why you say well, it’s better if we didn’t get vaccinated versus you know, facing the virus itself. And that’s true and his perspective. But if you go to perspective of Dr. Peter McCullough, he will say well, I can reduce the debt 100 times if we start early treatments, so I will I will even produce the same thing like what the vaccine is doing with almost no much of that money like trillions of dollars in developing vaccines. Of course, that’s not good news for the Big Pharma, or some doctors to say early treatment will reduce the death of the COVID-19 100 times which is equivalent to the vaccine and this will bust the trillions of dollars of the Big Pharma is going to produce and that’s why they hate Dr. Peter Makala. Because it’s not he’s not preaching what line up with the Big Pharma. And I think you’ll be pleased more if you are helping the interest of or or you’re preaching and you are presenting things that lines up with interest of the Big Pharma. Anyway, let’s go ahead and finish up what he’s saying. But there’s only two deaths and they stopped this CTL respiratory syncytial virus.
37:58
But we recognize that it’s a real problem for certain respiratory virus vaccines that killed the RSV program for decades now the Gates Foundation is taking it up again. But when we started developing Coronavirus vaccines in our colleagues, we noticed in laboratory animals that they started to show some of the same immune pathology that resembled what had happened 50 years earlier. So we said oh my god, this is going to be problematic. But we collaborated with unique group that figured out how to solve the problem that if you narrow it down to the smallest sub unit, the piece that have what’s called the receptor binding domain that talks with the receptor, you get protection, and you don’t get that immune enhancement phenomena. So we were really excited. So let’s talk
38:41
about what he did. Okay. So, they took the the spike protein and they clip it, what they could do remove all the epitopes that will lead to polarization to th two and they left on the the piece of the spike protein that react with the receptor, which is the ace two. But the problem is if you blocked the ace to interfere with renin angiotensin system, and you lead to over activation of angiotensin two type one receptor signaling, which leads to expression of interleukin six and polarization to tf 17. And interleukin six itself is the pathophysiology that is behind the neutrophilic pneumonia. So with his method, he may be able to clip all those epitopes that leads to hyper immune response to th two and is an affiliate of pneumonia. That’s true, that’s what he did. He sold that problem of polarization to th two by clipping all this epitopes that leads to stimulation of the macrophages into into m two and th two, but he did not solve the problem of the blocking the ACE two which leads to polarization of the immune system to D at 17. So they still have the problem. And maybe he solved the problem of his an affiliate pneumonia, but he did not solve the problem of neutrophilic pneumonia and neutrophilic vesicle mites and that’s the problem with with with a vaccine development. The other problem is that you are polarizing the immune system to th two and th 17 And you’re producing antibodies, and as antibodies they they can neutralize the viruses and they based on the success of their buys. The antibody titers, okay. But that’s not the way we determine the success of the vaccine because it’s not just enough to have enough antibodies have high antibodies, even high antibodies and polarization to th two it’s not good because that’s when you have too much of what you’re looking for which will suppress your cytotoxic T cells and th one so you need to have a vaccine that gives you a balance. Some it gives you some antibodies but a lot of cytotoxic T cells. So really the vaccine that’s effective is the vaccine that can give you th one and cytotoxic T cells. And that’s not being measured. They don’t care about it. They just prove that to the public or to the FDA, hey, we have a lot of antibodies here it’s either vaccine, but that’s not the way that we measure the efficacy of the vaccine. You really need to have both the th one immune response of th two antibodies and cytotoxic T cells if you have too much of antibodies, that’s a bad vaccine, because you’re suppressing the cytotoxic T cells. Now what will happen? Well, first of all those vaccine will definitely will not stop the transmissions. And the reason because those vaccines we introduced it intramuscular so you’re getting all this IgG but you’re not getting any IGA. So it’s better if those vaccines be introduced into nasal to the mucosa so that you can get IGA so that’s what so you’re not getting the vaccine when I stopped the transmission. Although, and one of those lecture he’s saying those vaccines stopping the transmission. So that’s this information. Now, the other part
42:06
is that, you know, those vaccine is giving you antibodies, and it will not July’s the free viruses, but it will not destroy those infected cells with viruses. So what would happen to those viruses you are pressing, putting pressure on them, where they start mutating inside those cells has been infected and change into variants. So the vaccines actually leads to pressure evolution of development of more variants and that will prevent us from getting into the herd immunity. So that’s the problem with a vaccine. The whole valiance is being pushed by the vaccine because the vaccine is not clearing the cells from from the virus. So we’re going to see that learn that from the coming slide. We’re doctors soon, Patrick he’s from South Africa is the billionaire. The most intelligent doctor that I know he’s like unmask think he’s an intp. And he’s explaining that we need a vaccine that gives you th one inside the toxic T cells to clear those infected cells with virus and prevent the pressure evolution of the variants and preventing us from getting into the herd immunity and prolonging the whole epidemic to two years. I think if we if we’ve developed the right vaccine that gives us th one and we develop a vaccine that does not block the ACE two receptor maybe we use the capsid of the virus instead of the spike protein itself. We may be having better vaccine but we don’t have that really good vaccine, the vaccine that develop it’s all based on the spike protein and the spike protein is pathologic so you cannot really develop vaccine from toxic or toxins and very important that people need to know here that those spike protein how they came up from I mean, Where’d they come from? The idea of developing spike protein, it came from the snake venom. So snake venom is the way that we can get peptides. antihypertensive drugs Captopril Enalapril is no Braille. So there’s no Braille Captopril Enalapril are peptides originated from the snake venom poison. So we have developing medication from the state bundle and they block the ACE receptor not h2 But ace receptor and Ace receptor. We block it prevent the conversion of angiotensin one into angiotensin two which will prevent you know, producing this angiotensin two which is which is goes hypertension right. So it’s blood it’s preventing that so that lower the blood pressure which is good so that we use for medicine. But But and developing the COVID SPIKE protein. They same thing they both from the vaccine but they blocked the ACE two which is the enzyme that convert angiotensin two to angiotensin one seven and once you tensing one seven responsible for anti inflammatory and vasodilation it’s the opposite of angiotensin two. So if you blocked that you’re blocking the vasodilation and anti inflammatory allowing this inflammatory signaling mediated by angiotensin two and angiotensin two type one receptor to lead to all this problems, which is that cytokine storm and interleukin six overproduction and polarization to ts 17. So that’s how they engineered or they came up on the spike. It’s come from the poison because there’s no much difference between ace enzyme and h2 It’s almost similar. And it’s so easy to tweak those peptides or create peptides from the venom that will block the h2 the same way we develop peptides that blocks the ACE and we use for medicine. We can also develop peptides and proteins or spike proteins from the snake venom to block the h2 and posting the whole universe. And that’s the gain of function. It’s a biological weapon. So let’s go ahead and finish up what Dr. Beter pod is saying here about that we need enough time to pass the safety this is before he received the fund Okay.
46:14
About that and we propose this to the National Institute of Allergy and Infectious Diseases. They funded it and we wound up actually making in manufacturing in collaboration with Walter Reed Army Institute of Research a first generation SARS vaccine. So SARS was the one that emerged in 2003. And then this new one of course we call the SARS to Coronavirus. We had it manufactured but then we could never get the investment to take it beyond that. And then so that was really unfortunate because we had the vaccine ready to go but we couldn’t move it into the clinic because of lack of funding because by then nobody was interested in Coronavirus vaccines. When the Chinese started putting up the data on Bio Archive in January February, we saw very close homology between the two and realize that we may be sitting on a very attractive Coronavirus vaccines now we’re working with again with NIH and will work with BARDA and others to get the funding but now we’ll have that lag and these clinical trials are not going to go quickly because of that immune enhancement. It’s going to take time so you know all and unfortunately, some of my colleagues in the biotech industry are making these inflated claims. You know, you’ve you’ve seen this on the newspapers, we’re going to have this vaccine in weeks or in this and that. What they’re really saying is they can move a vaccine into clinical trials, but this will not go quickly because as we start vaccinating human volunteers especially in areas where we have community transmission, we’re gonna have to proceed very slowly, very cautiously. The FDA is on top of that they have a great team in place at the Center for Biologics Evaluation Research. They’re aware of the problem, but it’s not going to go quickly. We’re going to have to follow this very slowly cautiously. To make certain we’re not seeing that immune enhancement. So you know, now we’re hearing projections year 18 months, who knows this is this is not going to go quickly. The bottom line is had we had those
48:11
eight months. That’s the minimum right. The reality is that Trump did push the whole thing into less than one year, less than that maybe a few months and they say okay, we go emergency permission licensed and they got this emergency license and they start putting it on people and we got almost bought 00 2% debt, which is 14,000 Among 500 million people being vaccinated United States. So that’s the data. Okay, so that’s the problem. So the safety was not been, I mean, looked at and they pushed the whole thing and we ended up with this death and also not just that the number is going to be very high with the side effects that and triggering subclinical current disease to become chronic diseases or even diseases out of the blue. So maybe somebody has subclinical multiple sclerosis, but because the vaccine they have blow blow and multiple sclerosis baby there’s multiple sclerosis which preclinical it’s about manifest at the age of 80 manifests at the age of 50. And it’s because of the vaccine still, the vaccine is blind even if they have some clinical and genetic print of risk of having chronic disease. So this is the problem that we have with with with the vaccine. It’s because of sticking into developing vaccines based on the spike. And I think that’s the mistake here. We may be able to create vaccines from other parts of the virus more safe than the spine. And we’re going to learn that from the coming slides from Dr. Patrick soon, which is a South African doctor. I like this doctor, but let’s go
49:58
early on to carry this all the way through clinical trials years ago. We could have had a vaccine ready to go.
50:08
Okay, so let’s go ahead and and check what Dr. Patrick Suen is talking about developing a vaccine that leads to memories of th one that’s ended up 60 cells not just th two because th two vaccines that leads to antibody based is not enough and it may actually cause problems. And it can cause pressure evolution of of developing variants. So we’re going to learn that from Dr. Patrick Stewart and how he developed a vaccine, not based on the spike, but based on the other parts of the virus that caption and I think Dr. Patrick soon did nail the whole idea of developing th one based vaccine is here. What do you say?
51:05
What do you think of boosters? Will this increase efficacy against for example, the Delta variant?
51:12
Well, that’s what we actually pursuing. And the good news is we’re in a phase 123 trial right now. And we decided to go into the heart of the stone where, you know, obviously the initial variant now the Delta Baron and soon the lambda variant, and this inevitability of the viruses changing against antibodies means that you need both an antibody and the T cell. So I’m excited to tell you that we’ve launched phase 123 trial in South Africa, again, boosting both the Johnson Johnson and the Pfizer vaccine, and the first patients will probably be injected to jab this week.
51:51
Now I felt pretty good with the fact that I got double vaccinated by the time the summer has started. But of course delta is a different challenge. So when we think about the booster shots, either sobering conversation on another show yesterday with someone from the space and basically said that I share that a third MNR mRNA shot is the ticket here that it’s going to have to be something else in the therapeutic space a different way of going out is this sort of the point that we’re entering now in the pandemic.
52:15
Well, I’ve been, you know, screaming with the top of my lungs for the last year, that just trying to block the virus with an antibody is insufficient, you have to actually kill or clear the infected cell. Not only to prevent transmission, but to actually give you long term immunity and the innards of the virus called the nucleo capsid is what we’ve actually done. And I’m excited to say that preclinical data show that in fact, we protect all the way all the way to the Delta period. So I think the combination of a antibody vaccine and a T cell vaccine is going to be the answer.
52:55
Why doesn’t the FDA fully approve the COVID-19 vaccines out there? We’ve got so many people who are hesitant to take the vaccine, a lot of them surely are concerned about, you know, because of misinformation that they’ve seen on social media, but others may be looking at the FDA and saying I’m not going to take it until they approve it.
53:17
Well, it’s you know, I think the issue with regard to vaccinology is really long term immunity. So you know, I can’t speak to what the FDA is decision making process is, but I do believe first that everybody should get the vaccine because it definitely reduces death risk. But we need to go to what I call now the second generation vaccines and as we said, immunity bio is now taking the approach that we will become the universal boost I think long term, we need to figure out an RNA and DNA vaccine combination where the RNA looks as if it gives you the best antibodies and the DNA looks as it gives you the best T cells. So if one can then create what I call a heterologous vaccine, but right now what we’re doing we’re taking our DNA vaccine and at immediate bio and making that the third booster so to speak of both the Johnson and Johnson and Pfizer vaccine in South Africa.
54:11
To get people on board with this, is there a mind shift that’s needed in the sense that for a while we were hopeful that this first round of vaccines, whether it was from Pfizer and Maderna, where the answer is that they simply bias time to get to other solutions, like the kinds of things you’re working on?
54:26
Well, that’s exactly what I was concerned about. Right. To me, this first vaccine of first generation of antibody based vaccines is really important because it actually would stop the death rate reduce the the load on the hospitals, but it doesn’t really affect transmission, meaning the ongoing pandemic and what’s worse the transmission and those aren’t vaccinated as you could see from the results. We’ll continue this pandemic. And then if you add to that concept that the virus will just mutate against an antibody. So it’s so important and so urgent that these next second generation vaccines now come to fall. Unfortunately, with the supply chain being sucked up by the first generation vaccine, we have a sort of vicious circle, where we can’t produce enough at the second generation in order to enable this to come to the full and that’s really where we are actually at Demeter bio. So we’ve taken the position that we need to go country by country at a time. So we started in South Africa.
55:25
I’m sure it’s way down on your list of concerns. Doctor, but You famously own a stake in the Lakers and I just wonder what you think about fans being able to come to the games this year. You’ve just added Russell Westbrook in the offseason, he’s surely going to be a draw, but are people going to have to you know, wear a mask while they watch?
55:48
Well, even more so instead, this is the disconcerting factor where when you look at it both scientifically and logically, when we were concerned very early on the very early stage of the pandemic of what you call asymptomatic infections that you would be asymptomatic and could spread then all of a sudden, CDC said we’re masks. Guess what, when we get the vaccine when people get vaccinated versus those unvaccinated and the person who is vaccinated that’s infected. This delta variant actually has five to maybe 1000 times more viral load in your nose so it’ll only affect the unvaccinated and even those who aren’t fully vaccinated, as you know, is people that will break through infections. So the concept of now not wearing masks is really little illogical. It’s actually worse now than it was even breaking the pandemic. So,
56:40
Doctor unless you unless you say, you know, players have to be vaccinated and you’ve got to be vaccinated get tickets to come to the game.
56:48
Vaccinated doesn’t mean you’re not gonna be you don’t prevent transmission. That’s the whole point.
56:53
But you’re not going to end up in the hospital. You’re not going to you’re not going to take away from a cancer patient, you know,
56:59
but But putting a mask on it’s not just for yourself, it’s for your fellow man. So putting a mask on is prevent transmission to others. So we can stop the cycle of pandemic right of infection. So now look, I I personally advocate masking when you when you’re inside or outside. It may not be the
57:19
so I mean, we’re not saying everything is saying I like everything, but there’s some points where he said that the so we know that the vaccine does not prevent transmission and that’s true and he confirmed that which is good. So that’s one point. Now lowering the risk of dying from the from from the COVID 19 virus versus the vaccine, it’s one other time and that’s what he’s trying to present that, you know, taking vaccine is you die that 100 times less than then facing the virus itself. But then the other side, which is the red side of the aisle, Dr. makalah will say well, I can reduce the death rate from facing the virus to 99% to 1% death rate, which is equivalent to what the vaccine can do just by early treatment. Oh by by all this repurposing drugs, so he has a point there and it’s more efficient. And then this natural infection, you would have mucosal immunity. So you can prevent transmission, if you are recovered from COVID virus infection, because you do have immunoglobulin A and you recover. So there is no much if you covered from COVID-19 You’re not transmitting the virus as as he indicated, versus the vaccine is not giving that protection against transmission. And the other part of the vaccine is pressuring the virus to evolve into variants. And that’s a problem where he’s gonna solve it with his T It’s th one vaccine. But Mokhtar Bacala was say, I can only treat those patients and they get their natural immunity, they prevent the transmission and we can reach the herd immunity and we’re not getting this 100 times more than the vaccine death rate. We can do that with early treatment and that will reduce the death rate versus the vaccine. So that’s the argument of both I’ll think you osteopathic doctors will you will agree more about early treatment. It’s more effective, more efficient, you get the herd immunity and you can get the same level of the vaccine. But the people are developing vaccine Big Pharma of interest. They’re definitely they don’t want early treatment, because that will destroy the purpose of developing a vaccine which is lowering the severity of disease and if that early treatment accomplish that, then there’s so much purpose there because even transmission, it’s better to be recovering from the natural infection versus the Bechstein. What’s so that’s the argument of both sides and we just country now, let’s let’s learn about Dr. Beter. Hotez when he is developing the vaccine, and he trimmed the spike protein I said mentioned the spike proteins came from the snake venom. That’s the gain of function that blocks the h2 but also the spike proteins that didn’t have the virus or that been expressed by the vaccine. They do have epitopes that may lead to polarization of the immune system to th two so he said okay, we’re going to take this and we’re going to trim them’s the one that produced epitopes that polarize the the macrophages into m two and th two and give you as an affiliate pneumonia, but he forgot that blocking the ACE two will lead to polarization to th 17 lead to neutral feeling. It will feel like the morning so let’s go ahead and see that he’s so excited and happy that he solved the problem of his inability pneumonia and hyper immune response from kids to but the problem is that he did not solve the problem of of the neutrophils and pneumonia mediated by dF 17 hyperimmune response due to blockage of the h2 enzyme. So let’s go ahead and learn that.
1:01:39
Okay, thank you well, for having me and I’m sorry we had a couple of technical
1:01:46
difficulties but just two minutes, okay. Permission to move
1:01:53
forward in the lab. So, the great thing about these receptor binding domain vaccines, the spike protein they seem to induce high titers of neutralizing antibody depending on the adjuvant that you use, it seems to remove a lot of the immune enhancing spike protein epitopes. And as I said, this yeast expression system, and when we initially looked at this, it was amazing how quickly the scientific community was responding putting out their data on Bio Archive. I’ve never seen anything quite like this. But we were able to ascertain pretty quickly that SARS one and SARS to look pretty close. So we thought we’re going to try as best we can to do this in a staggered way. We have the receptor RBD one ready to go now and then we’ll advance the RB two and this is our RB one receptor binding domain SARS one candidate, we call it it’s got the very memorable name of RBD RBD to 19 and one and the reason we call it n one is our scientists found that if they express it without the N terminal amino acid, then we get higher levels of expression yields are also one of the problems with Pikia Pistorius one of our lead workhorse expression vectors is they can overclock constantly and by getting rid of that and terminal amino acid we did not affect the conformation of the protein, but got rid a lot got rid of a lot of the glycol installation window dressing and we were getting really good expression yields. So we were able to show in a transgenic mouse model working with Galveston national lab they have a mouse model with expressing the ACE two receptor, the angiotensin converting enzyme to receptor or they will also got a mouse adapted CRO SARS SARS will and Coronavirus. We were able to induce very high levels of neutralizing antibody and interestingly we found it now hydrogen hydrogel straightforward alum was one of the best adjuvants in inducing protective immunity. This is the survival curves of our RBD 299. One construct their complete survival versus total death among our mice that were not that were vaccinated with the UN alone. And this is people talk a lot about immune enhancement but not many people actually show what it really means. This is what it looks like. This is using history looking at histopathology in the lungs are vaccinated versus control mice. And those brown dots are immunohistochemistry of eosinophils. And you see that with the full spike protein, kind of reproducing Lenin’s original observation lots of eosinophilic infiltration, but if we can get the hydrogel right we can completely prevent eosinophilic immune enhancement. So we were pretty excited about this because we had a vaccine that worked and it was safe and now Len Yang has taken
1:04:56
the vaccine is saying that’s not true. And yes, he solved the problem of hyperpolarization immune system to the h2 and he’s gonna He’s gonna beg for money Madea but he did not solve the problem of hyper immune response of th 17 and introducing six and neutrophilic pneumonia. So that’s the problem with with the vaccine. So, adding adjuvant like interferon gamma thymosin alpha to the vaccine, possibly that may help to polarize the immune system into a th one because they did it for influenza virus with success. So I don’t know why they’re not adding that because that may help to push the macrophages from polarizing into th 17 into macrophages from M 17. To add one and then th one cytotoxic T cells. So this may be we may add that interferon alpha gamma thymus and alpha may lead to polarization of th one and that will prevent the polarization to th 17 and neutrophilic pneumonia, but nobody I don’t know if they thought about it, but he doesn’t have a clue about yet. 17 These those old school people and I was one of them before before we learn about yet 70 We only know th one th two so they think he he’s still in that that circle and they did not break through understanding that there’s also just 17 which is mediated by that ace two blockage which is blocking the anti inflammatory arm of the angiotensin two allowing renin angiotensin system allowing the angiotensin two to over activate the angiotensin two type one receptor signaling that leads to introducing six expression and neutrophilia and hyper coagulation and then atrophied neutrophilic pneumonia and neutrophil Invesco lights, which leads to this multi organ failure that we see in patients whether they are receiving COVID vaccine or they are facing the virus itself. Okay.
1:07:01
So let’s see about disinformation here. And where were the media the CNN and left wing Doc’s and the media and BBC wherever from where they learn that ivermectin and hydroxychloroquine are drugs for treating malaria and, and parasites. Okay. And they’re using ivermectin to treat hoarse parasites from where this idea came from. Yes, it is. That’s true amino. ivermectin and I talked to the clerk when that antibiotic effect and they kill the malaria and and we use it in for treating parasite the warms and so it has anti parasitic effect and also they have that anti malaria effect that we generally would say antibiotic, but also what he’s missing, that those two drugs, they also have anti inflammatory effect. That’s why we use FDA FDA approved ivermectin to treat the possession because it was Asha is skin disease mediated by th 17 and neutrophilia. And we get over makes it the only effective drug that suppress the th 17 06 expression is using ivermectin topical and it’s FDA approved. And my wife is using it and I think my wife is a human on the horse and hydroxychloroquine is being used for as an anti inflammatory to treat systemic lupus erythematosus. It’s an FDA approved because as il e, it’s the at 17 dominant immune disease, but because of the ignorance and disinformation of those left doctors who have no clue that those drugs have anti inflammatory effects, especially tea at 17, anti inflammatory effect, we know that our group I think everybody here we learned that there’s two kinds of inflammation. There’s th one and 70 and it’s true. They’re not just one inflammation and in order to manage disease more effectively, especially inflammatory disease, autoimmune disease, we need to learn which inflammation they have is it th two, th one is Did somebody and maybe you have MCs you may have th one and th 17 right like multiple sclerosis, or you may have th two and th 17 Like celiac disease for example. Or, or psoriasis or Sasha you have lots of kids 17 there, so we can give drugs that inhibit the th 17 without affecting th one which is that’s very important because if you give steroids, steroids suppress everything, including th one and that put the patient is at risk of having cancer and viral infection. So you don’t want that you just want to block that inflammation that’s been active, which is th 17. And let’s go ahead and see the disinformation or lack of knowledge what’s sarcastic that hydroxychloroquine and malaria it’s only antibiotics and it’s only for parasites and malaria and worms and it’s not for other inflammatory disease because he has no clue about what he’s saying. And this will be in the section I think,
1:10:28
an important story that we’re working on today that because of the adverse effects with the vaccine, not because kids are getting COVID
1:10:37
No, pediatric hospitalizations are way up. A lot of it is due to COVID. Also we have a second virus pathogen circulating known as respiratory syncytial virus RSV, and we’re even seeing kids now with combine RSV and COVID. And masks can help with both of those illnesses. But no question. We’re seeing a big rise now in pediatric hospitalizations from COVID. None of it is due to the vaccine
1:11:04
More people have died from the COVID vaccine.
1:11:09
Vaccine 620,000 Americans have died of COVID 19 my knowledge no one has died from a COVID vaccine. And now Now,
1:11:18
if you take hydroxychloroquine ever Min 10 and zinc you can be COVID Easily.
1:11:25
Know if you take hydroxy, Chloroquine and ivermectin, you will have some protection against malaria and and against parasitic worm infections, but it won’t do anything for your COVID
1:11:40
your immune system is 99.9% able to beat COVID and it’s a vaccine that actually lowers your immunity.
1:11:48
No, that’s not true at all. And that’s why 620,000 Americans have lost their lives and because they because the immune system cannot handle the virus and the fact that we are seeing this dramatic increase in hospitalizations from unvaccinated people so it
1:12:05
goes back to Bridget McCall was say all this death is because of lack of protocols apparently treatments. And at that beginning, those those patients who have COVID They tell you know stay at home until you get respiratory failure in your oxygen is low and then come and they end up with hypoxic pneumonia. And that’s the problem. Lack of early treatment. If we have the early treatment protocol we can reduce the death rate the same and equivalent to what the vaccine can do. But Dr. Peter Hotez does not recognize early treatment and because early treatment will negate the interest of doing the vaccine. Okay, so is it too much? Is it too heavy or you want me to continue? Dr. Williams, are you there?
Bill Clearfield 1:12:56
You can hear me go and keep going.
1:12:58
Keep going or you want to have some break and some QA and do other sessions. You want to do other sessions. We’ll
Bill Clearfield 1:13:07
we’ll do other sessions but we keep going for now. There was a question here. What was the third type of inflammation?
1:13:16
So we have three kinds of inflammation th one mediated inflammation like contact dermatitis TB, those are th one mediated and then th two mediated inflammation where you have his you know theory and based on failure that allergies, parasitic infection leads to th two inflammation, celiac disease this to th two inflammation and then the th 17 mediated inflammation is like psoriasis or Sasha COVID-19. Those are th 17 mediated now there is some mix, you know COVID-19 There’s some th to also immune inflammation mediate inflammation, but it’s more th 17 In case of COVID-19 because we know that h2 is responsible to break the braided guidance because it’s been activated by the virus so you have activated kinase to release of interleukin four and histamines so you have some histamine syndrome in those patients, but it’s more dominant of th 17 Because we see neutrophilia don’t see is in a field on basil philia. Maybe the original vaccine and that develop leads to more of tears, too. That’s why you see that in the case that the original vaccine was giving them as an affiliate pneumonia. But once they trim that it’s actually giving us a neutrophilic pneumonia so it’s that indicate it’s more kids 17 than to chew but there’s some components of h2 there. So most of the time the autoimmune diseases and degenerative diseases and inflammatory diseases. You can see a mixed bag of th one th 17 like multiple sclerosis, or in all sorts of collides, you will see T at 17 p h2, which one is dominant you see go to CBC differential and if you find it to feel as dominant that’s mean it’s more th 17 If you see that it’s in a feeling basil field, that’s mean it’s th two but when you see lymphocyte as lymphocytosis that’s mean it’s more of th one along I mean there is some exceptions there like Dr. Patel when she got she bought the patient. One year old patient with high CBC was not that high. It’s 18,000 for the kids at that age, the max norm is 17,000. But she the patient is exhibited manifesting is in a failure and and lymphocytosis and possibly the lymphocytosis is due to CD four, which is the th two over activities and that’s why we need to measure the CD for CDA ratio to know exactly what kind of lymphocytes is causing them for psychosis. So if it’s CDA, you know, that’s mean maybe they have some infection viral infection that leads to lymphocytosis. But very clear that Celiac disease is th two dominant and some of th 17 as well, but because of too much of is inferior there so we can know that’s going to teach too. So those are things we need to learn. And we’re going to have maybe a complete the presentation of just focusing on all the varieties of disease and there whether they are th one or th two or th 17 are both mixed. We need to really any disease out there, whether it is degenerative metabolic we need to look and screen the metabolic or the immune polarization it’s very important so that we can give the right peptides and the right drugs to balance the immune system. In case of cancer we all the time want to polarize the immune system into th one and one is like toxic T cells, because that’s the only way we can kill cancers. And the cancer are secreting chemicals to polarize the immune system away from cytotoxic T cells to th 17 and th one so we’re giving drugs that polarize the immune system th one and one and blocks it yet 17 And th two including, you know methylene blue, you can use ivermectin or you can use anti histamine in those cancer, or we use antibody blockades as well, PDL one and CTLA four. That’s that’s complete another lecture, but it’s very important to screen your patients with chronic disease screen their immune polarizations and knowing exactly what direction they are in trying to balance it. And we’re going to learn that through the sessions that we have here with Dr. William or through my sessions in current disease prevention. And then also in chronic disease you need to manage metabolics all the metabolic clinics exam are very important, especially post COVID-19 With all the cytokine and interleukin six and neutrophilia and this leads to mitochondrial dysfunction entity dysfunction and autonomic nervous system dysfunction. And that leads to the post COVID-19 syndrome so you need to really restore it. And in addition to this, the the inflammation of COVID-19 and interleukin six and all this free radicals it can damage the testis and the ovary and can damage the brain, the pituitary glands, and it can lead to hypogonadism. And we saw cases of patients where they have Lotus testimony due to the vaccine or due to the COVID virus. So it’s very important to check all your patient with post COVID-19 syndrome or bass COVID-19 vaccine injuries with their sex hormones. It’s very critical. I think Dr. Patel she has a very interesting case about that. I think she presented the patient was having l posts due to post COVID-19 vaccine injury.
1:19:14
Any other questions? Are we good?
Bill Clearfield 1:19:21
Let’s see vaccines have shown not to prevent the spread. No evidence of the vaccine has reduced death in fact now that’s
1:19:29
Well, well, we need we need to make sure that we go with that. And the CDC said we have point 2% died from COVID and point 00 2% died from the vaccine and as too much as 14,000 It’s a lot. I mean, they stopped the vaccine program other spiders and city virus just for two cases not 14,000 But that’s how they minimize it. They say you know just volunteer to and it’s 100 times less than that you receive if you if you face the COVID and the argument this is how you you argue with them, you don’t argue with them with the data that they believe if you tell them hey, but if we do early treatments, we can reduce the death into less than 99% which is the same and equivalent of what the vaccine can do. We can go from point two to point 002. If if you start with early treatment, and that’s proven fact, if you start methylene blue and ivermectin which is again, we’re not using ivermectin because of its antibiotic, although, although you can argue that the ivermectin does block the spike receptor, okay, and preventing it from mentalization. So that’s antibiotic. And methylene. Blue does the same thing. And hydroxychloroquine does the same thing. But you can argue that we’re using it also for its anti inflammatory effect by inhibition of kids 17 And interleukin six expression of polarization so that’s why we’re using it and of course in COVID-19 It’s good to view is thymosin Alpha interferon gamma, anything opposed to th one and balanced immune system? It’s great and we have a complete ingredients with supplements or repurposing drugs that we developed for for post COVID-19 and as well and for for COVID patients. So I think that’s a better argument with a mainstream medicine doctor will bring the facts from their own CDC. I think this is how you answer that in a way that we are, you know, at this we have some common ground to discuss.
Bill Clearfield 1:21:39
You only you’re a big advocate of phototherapy. Also, at least early on. Where are you with that?
1:21:47
Well, that’s what we started with. We know that the virus the virus concentrate mainly in the salivary glands and the beginning and the esophagus. But salivary glands is really the place where they replicate and they proliferate. And so with metal and blue mouthwash, or even you can swallow the methylene blue because it does have antioxidant effect and it blocks interleukin six and you do light therapy, you can really enhance the antibiotic effect of the methylene blue In addition, you get the benefit of its anti inflammatory effect by blocking the interleukin six expression polarization to th 17 And it’s very important, and plus the methylene. Blue does help to restore the mitochondrial function. And that’s part of the thing that we knew, especially with cytokine storm with all these free radicals, it can definitely oxidize the site of the cytochrome iros in the mitochondria and cause mitochondrial dysfunction so you can restore the mitochondrial function using methylene blue and methylene blue also helps to kind of involve an electron transport and bypass the blockage caused by the free radicals damage of the mitochondria, so it will restore the electron transport chain and the energy flow and production of ATP. In addition to that methylene blue is acetyl cysteine which is very important. Why because there’s some theory that the COVID-19 blocks and nicotine receptors and cause autonomic dysfunction but methylene blue blocks acetylcholine strays and that helps to prevent the blockage of the nicotine receptors. And in addition to that methylene blue block it’s a Serotonin Reuptake Inhibitors so thinkpieces serotonin and we know that the approved serotonin reuptake inhibitor to treat COVID-19 Because serotonin inhibit that polarization to tea at 17 m 17. So it’s an anti inflammatory drug. So serotonin, so serotonin reuptake inhibitors, methylene blue, those are FDA approved serotonin reuptake inhibitors, those drugs that we know for treatment of COVID-19 and the mechanism instead of trying to happen to Newton six. So methylene blue does everything I mean, if you see it, it does work on old aspect to manage the acute phase of COVID-19 and if you add the light you activate you generate free radicals you can kill more of those viruses and it will help to balance the the immune system that metabolic and the redox when we are facing the post COVID-19 syndrome and those fatigue and endothelial dysfunction and mitochondrial dysfunction due to the cytokine storm and due to this free radicals that’s been generated during the inflammation.
1:24:41
It makes sense. Thus, yes.
1:24:45
And that trick some is very good. Dr. William is very advocate for naltrexone low dose because natrix inhibits M 17 and th 17 polarization. So it’s a treatment ultra low dose, and they work the same like peptides tantric Sunday, they work on toll like receptors and the macrophages and they inhibit the polarization the macrophages into T and 17. So I will add low dose Naltrexone in the equation. I will add poly phenols I will add antihistamine I will add methylene blue, ivermectin I will use an acute phase but for post COVID-19 I would like to use this methylene blue and poly phenols and peptides thymosin alpha, I will not use diamonds in beta. The reason I need to check them in balanced autoimmune. We call them the lymphocyte mapping and cytokine profile and see where the immune is and if it’s polarizing into th two and th 17 You really don’t want to use thymus and beta here you want to use thymosin alpha to restore the balance and the polarization to th one and sometimes the cells. We know that that that COVID virus and post COVID Because of this circuit and vicious circle of activation of T and 17 and two NewCon six in this inflammation and then mitochondrial dysfunction and also disinhibition of the nicotine receptors and all that you will end up with the vicious circle of Ts 17 inflammation and what will happen is that you’re draining your immune system to build or to do have neutrophilia are draining the immune system into th 17 inflammation and what will happen you will have less of an immune surveillance of cancer through th one and cytotoxic T cells. So this will put the patient at risk of having cancer or a patient is in remission, then they would have recurrent cancer because they don’t have much of th one and th and cytotoxic T cells to kill those cancers because the immune system is being drained and polarize due to this COVID-19 due to interference of Ingredion angiotensin system and to th 2017 So that’s why the number of cancer cases will increase after this post COVID-19 syndrome. And we saw that and there’s articles publications in addition of real clinical cases back Dr. Patel are so have a case with breast cancer due to post COVID Either because COVID virus or post COVID vaccine I don’t see much difference between them because both of them are expressing this pathogenic spike protein. Any other question? Are we good? We are good. So we can do more sessions is better because I think I did too much today. Right? And a lot of okay. And I don’t want to you know, drain your people from the person so they can take it. You want me to continue you want me go ahead and do it next session? Both oh, let’s make it let’s make a boat. Do you want to continue or you want to have divided into sessions, sessions or whatever, just text and let us know and then we count them
1:28:27
great I greatly appreciate what’s being taught, but I think it’s very, very worthy of a next and the next session.
1:28:36
Yeah, I think it’s better I don’t want to put okay much because it’s very stressful. Those information. require time for processing and digesting. When you come next time, the next session, we can go through the slides more easy because we have some Vaser Okay, great, beautiful. Okay.
Bill Clearfield 1:29:03
Okay. All right. Dr. Lawson. Oh, well I’ll get get with you to get the next session. I just want to say this. On the on the web, not the conference website. If you were at the conference and you have the password Dr. Mikolas talk that was two hours long. Whether you like them or not, is on there. And I’m going to put it on the free side to probably in the next day or two. Because I think it was it’s important to listen to it, you know, even if you’re 100% against what he has to say, he makes some very good points, especially about vaccine development and safety. And his take on how things have deviated in the case of the you know, these these vaccines here. So, if you do have if you are at the conference, if you don’t have the password to get to get to the slideshow, let me know. I think tonight, I’ll probably just send it out to everybody again, and I’m going to put it on our webinar or webinar site shortly so that anybody can listen to it for free. It’s almost two hours long. And those of you were there, notice us he’s quite the dynamic speaker. So with that, any questions, problems, comments? Next week Dr. Patel will be speaking for us again. And I do need speakers I have endless Tuesdays to fill up because I keep saying so. If anybody and this this is a good forum if you’re not used to speaking and you want to start becoming you know, becoming a speaker you want to start speaking you know we always need you know, content you don’t have to be polished. Nobody’s going to bite you here. Well, maybe Dr. Burgess but you know he’s he’s mostly harmless anyway. And so, comments, questions any any other questions for Dr. Kalasa? Oh, always thought provoking. And, again, if you look in the chat, Dr. Lawless you’ll see an arm’s length full of commendations for you here. As usual.
1:31:33
No, thank you very much. Okay.
Bill Clearfield 1:31:35
And so, thank you very much
1:31:41
for listening and attending and be part of this and we know we need to hear from you and I need to hear from everybody. I mean, we have Dr. Patel is active, Dr. Joseph James. So I’d like to hear from all of you guys. And so we can learn from each other. I mean, Dr. juicer, for example, he came up with a lot of new ideas. Dr. clads. For example, he said yesterday Hey, we need to really screen those people with the spike protein and we need to find a test to to see how we can measure it in the blood on the faeces. And I told them they’re already doing it. They have Eliza test so chromatographic test where they can detect the spike protein, the sewage so in order to know if there’s a spike in infection, they they take the sewage of that community and they can detect the spike protein and grease and if they find a spike protein fragments or whatever they are measuring, then that means that the COVID is increasing. And because of that, then there is tests where you can measure those spike protein into pieces, and you can use it as part of your diagnosis then you will know that those this fatigue and this sexual dysfunction and this autoimmune or dementia, it could be part of this patient is still expressing the spike protein and and those by vaccines. RNA are not completely biodegradable for some patients. And the virus. They say you know it’s an RNA virus and it’s it terminates once it’s been recovered. It could be those RNA reverse to DNA. We don’t know there’s some some articles of publication says that but shedding more than three months or six months of the spike protein indicate that there is some way of harboring those RNA whether reversing to DNA or they are stable and they don’t degrade. And they continue expressed and I don’t see that both the patient but some patients and then then we can really measure their spike protein and knowing that this is part of the pathology, this is what you’re dealing and we need to detox those spike proteins and the best way of detoxing them is using methylene blue because methylene blue combines with it. I mean you can use ivermectin but I prefer methylene blue for many reasons, because it has many other aspects of restoring the to function, mitochondrial function, autonomic nervous system. It also impedes acetylcholine so good for dementia. So there’s many things about it and it polarized the immune system or a balanced immune system. So that’s something that Dr. Class is emphasizing and adding it to our protocol. Hopefully that Mike beamer will be looking the lab to have that as a routine protocol for managing post COVID-19 syndrome. Okay,
Bill Clearfield 1:34:39
anybody else?
1:34:42
And Dr. Makala I think I can invite him to speak again here. It promises coming again. I did invite him to speak at Dr. Carterville by the way, in his radio show, and he said yes, they are arranging for him to speak there. But we may be need to hear from him. You know, especially with all this changes that’s happening, especially with this new restriction of Johnson Johnson Johnson vaccine. Just recently, I mean, this is like three four days because of the concern of calculations and declining effect that the Johnson Johnson only restricted here in United States but not overseas, so they can keep selling it.
1:35:29
Any other questions?
1:35:32
Everybody’s happy here. We’re good. We’re good.
1:35:38
Happy good.
Bill Clearfield 1:35:39
Okay. Dr. Burgess. You we have a short we have a few things to discuss. Yeah. Okay. Okay, everybody. Thank you so much. Quite well. Like last question. Dr. Loss is still there. Yes, I’m here. Okay. Are the increase in skin eruptions. Hives from th 17. What is that sorry. Or the increase in skin eruptions hives from th 17.
1:36:06
Well, it could be a combination of th 17 and th two so what I would recommend is doing cytokine profile to determine exactly what’s going on. But both can cause can eruptions. There is no failure and neutrophilia damage as we see and recessions arises. And we see in eczema Eczema is due to th two wild psoriasis and research it’s yet 17 So and it’s very important to know so we can emphasize on which one I need to inhibit or maybe we are both, but one is more dominant to others. So I can use both does that mean and I can use ivermectin I can use methylene blue, and all those are anti bodies that didn’t have it. Or there’s drugs that inhibit the expression of interleukin six. That’s FDA approved out there. They’re using it for treating loosens serratus. Alright, so it’s good to do an emphasize mapping and cytokine profile and do the ratio to figure out where it is and and then start working on the drugs that inhibit us inflammation specifically, instead of giving steroids which will then have all those three inflammation, especially with th one and then put the patient at risk of having cancer and viral infection. So I don’t like to use steroids all the way although if I see everything is high, then I will use a dose of steroid just to get into the edge. And then I will make sure that I will focus on that inflammation. That’s that’s that’s where the direction of the pathology is. It makes sense. Yeah.
Bill Clearfield 1:37:42
Okay. Okay.
1:37:45
Okay.
Bill Clearfield 1:37:47
All righty. Okay, Dr. alasa. will get together and we’ll
1:37:51
have a big crowd they stay up. We have now 27
Bill Clearfield 1:37:54
We had one right. We had 40 at one point. Here we go. You got the record there.
1:38:00
Okay, well invite them to my show to well, I’m by Oh my folks, by the way, today.
Bill Clearfield 1:38:10
Okay. All right. One last thing. We got a question about what types of devices for phototherapy? And are they quote unquote affordable?
1:38:23
I think they are. Mike beamer is the one who’s in charge on that. He has just he’s not. I mean, it’s like selling it for 100 bucks or something. 200 a good piece that put in your mouth for patient with the with COVID I do recommend it so you reach out to Dr. Mike beam or the pharmacist, Amex pharmacy, I think he has it and they they they got this device because it’s been published and Bahamas with Dr. Hepburn. And she has studies and data and publications showing the decrease in the viral load using methylene blue photodynamic therapy and he can share those publication with you. Okay.
Bill Clearfield 1:39:08
All right. All right. So yeah. So if you don’t know it’s a Mex pharmacy in Melbourne, Florida.
1:39:18
Right, just ask for Mike Beamer. And he will text me or text Dr. William he gives you the phone number. And having a pharmacist on your side is good thing especially you know those intelligent pharmacies gonna admire Oh my God.
Bill Clearfield 1:39:37
Oh, okay. All righty. Okay, everybody. Is this a confidential meeting? Dr. alacer. Is that open? Anybody? Watch. Dr. Berger. Dr. Burgess is this confidential but we need to talk about her you’re muted.
1:40:02
Can’t wants to talk on the phone. I think he’s on the road right now. Okay. I’ll call you on the phone too.
Bill Clearfield 1:40:08
Okay. All righty. Okay, everybody, Dr. Dr. Patel will be with us next week. And we will certainly have Dr. Philosophy back shortly. Dr. Zarin and I are planning the last Tuesday of the month, our sort of mini course and we are going to be speaking on the psychiatric psychiatric illnesses secondary to chronic traumatic brain injury. That’s our that’s our topic. Okay, and you know, since I’m going to be one of the speakers, you know, there will be a heavy emphasis on hormonal balance. So, look forward to that. Okay, everybody, good night. And we’ll have the, the we’ll have the video up as soon as we can here. And look, by this time next week, we certainly should have Dr. Dr. Nikolas. Talk up on the free free side on the Webinars side also. Okay, so thanks, John. You’re gonna call me later. Does that call you right now? Okay. Okay, everybody. So thank you so much. And we’ll see you again. Same time, same station next week.
1:41:26
Good night, everybody. You know, thank you. Thank you.